Flu vaccine study for adults 65 and older
Part of Infections, Lungs & breathing clinical trials.
This study tests a new flu vaccine in adults aged 65 and older to see how well it prevents the flu. If you are generally healthy or manage chronic conditions well, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 65 years of age or older.
- You are generally healthy or have stable chronic conditions (no major changes in treatment or hospital stays in the past 3 months).
- You have not had the flu (confirmed by a test) in the last 6 months.
- You are not allergic to any flu vaccine or mRNA vaccines.
- You are not taking medications that weaken the immune system (like certain steroids or cancer treatments).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new flu vaccine to see how well it protects adults aged 18 to 64. If you join, you'll get the vaccine and have some check-ups to see how your body responds.
This study gives you a flu vaccine and measures how your immune system reacts, including both “blood immunity” and “cell immunity.” It’s for healthy adults and mainly aims to better understand how well flu vaccines work in people without major health issues.
This study tests an investigational flu vaccine to see how well it protects against seasonal flu. It is for people ages 3 and older who have had a flu shot in the past year (for children ages 3–8) or have not had one recently (for ages 9+). The study will last several months and involves a few clinic visits.
This trial is testing whether a new mRNA vaccine that targets both seasonal flu and COVID-19 is safe and creates a strong immune response. It may offer an easier way to protect against two illnesses with one shot.
This study looks at how your immune system (your body’s infection-fighting system) responds during and around the time of a flu illness. It’s meant to help researchers better understand immune changes in healthy adults and may guide future flu care.
This study tests a new seasonal flu shot for people aged 60 and older. It aims to see if the vaccine is safe and how well it produces a protective immune response in older adults.
Hear when a new Influenza, Human trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.